大脑中动脉破裂动脉瘤的治疗模式:瑞士国家数据库(Swiss SOS)分析
该研究基于瑞士全国多中心前瞻性登记数据库(Swiss SOS)2009-2015年数据,回顾性分析1866例动脉瘤性蛛网膜下腔出血患者,其中413例(22.1%)为大脑中动脉动脉瘤(MCAA)。MCAA患者入院WFNS分级更高、合并脑内血肿比例更高(41.9% vs 16.7%),手术夹闭占81.7%,出院时良好预后率低于非MCAA患者(55.7% vs 63.7%),但1年随访时两组良好预后率无显著差异(68.5% vs 69.6%)。
要点
- MCAA患者入院WFNS分级更高(p=0.007),合并ICH比例41.9% vs 16.7%(p<0.001)。
- MCAA以手术治疗为主(81.7% vs 36.7%,p<0.001),MCAA位置是手术治疗的强独立预测因素(aOR 8.49)。
- 出院良好预后率MCAA低于非MCAA(55.7% vs 63.7%,p=0.003),1年随访无显著差异(68.5% vs 69.6%,p=0.676)。
核心结论
- 在瑞士这一欧洲工业化国家,显微外科夹闭仍是约80%破裂MCAA的主要治疗选择。
- MCAA患者入院分级更差且合并ICH更多,但院内死亡率更低,长期残疾与非MCAA患者相当。
研究设计与样本
- 回顾性分析瑞士全国多中心前瞻性登记数据库(Swiss SOS)2009-2015年连续入组的1866例aSAH患者。
- 比较413例MCAA患者(22.1%)与非MCAA对照组患者的治疗模式及出院和1年随访结局。
- 采用多因素分析确定良好预后(mRS≤3)的独立预测因素并测定效应量。
主要发现
- MCAA患者入院WFNS分级高于非MCAA患者(p=0.007)。
- MCAA患者合并ICH比例41.9% vs 非MCAA 16.7%(p<0.001)。
- MCAA患者DCI发生率38.9% vs 非MCAA 29.4%(p=0.001),校正混杂因素后无显著差异(aOR 1.04,95%CI 0.74-1.45,p=0.830)。
- MCAA患者手术治疗率81.7% vs 非MCAA 36.7%(p<0.001),MCAA位置是手术治疗的强独立预测因素(aOR 8.49,95%CI 5.89-12.25,p<0.001)。
- MCAA患者急性住院期间死亡风险更低(aOR 0.52,95%CI 0.30-0.91,p=0.022),但出院良好预后率更低(55.7% vs 63.7%,p=0.003);1年随访良好预后率68.5% vs 69.6%(p=0.676)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to determine patterns of care and outcomes in ruptured intracranial aneurysms (IAs) of the middle cerebral artery (MCA) in a contemporary national cohort. METHODS: The authors conducted a retrospective analysis of prospective data from a nationwide multicenter registry of all aneurysmal subarachnoid hemorrhage (aSAH) cases admitted to a tertiary care neurosurgical department in Switzerland in the years 2009-2015 (Swiss Study on Aneurysmal Subarachnoid Hemorrhage [Swiss SOS]). Patterns of care and outcomes at discharge and the 1-year follow-up in MCA aneurysm (MCAA) patients were analyzed and compared with those in a control group of patients with IAs in locations other than the MCA (non-MCAA patients). Independent predictors of a favorable outcome (modified Rankin Scale score ≤ 3) were identified, and their effect size was determined. RESULTS: Among 1866 consecutive aSAH patients, 413 (22.1%) harbored an MCAA. These MCAA patients presented with higher World Federation of Neurosurgical Societies grades (p = 0.007), showed a higher rate of concomitant intracerebral hemorrhage (ICH; 41.9% vs 16.7%, p < 0.001), and experienced delayed cerebral ischemia (DCI) more frequently (38.9% vs 29.4%, p = 0.001) than non-MCAA patients. After adjustment for confounders, patients with MCAA were as likely as non-MCAA patients to experience DCI (aOR 1.04, 95% CI 0.74-1.45, p = 0.830). Surgical treatment was the dominant treatment modality in MCAA patients and at a significantly higher rate than in non-MCAA patients (81.7% vs 36.7%, p < 0.001). An MCAA location was a strong independent predictor of surgical treatment (aOR 8.49, 95% CI 5.89-12.25, p < 0.001), despite statistical adjustment for variables traditionally associated with surgical treatment, such as (space-occupying) ICH (aOR 1.73, 95% CI 1.23-2.45, p = 0.002). Even though MCAA patients were less likely to die during the acute hospitalization (aOR 0.52, 0.30-0.91, p = 0.022), their rate of a favorable outcome was lower at discharge than that in non-MCAA patients (55.7% vs 63.7%, p = 0.003). At the 1-year follow-up, 68.5% and 69.6% of MCAA and non-MCAA patients, respectively, had a favorable outcome (p = 0.676). CONCLUSIONS: Microsurgical occlusion remains the predominant treatment choice for about 80% of ruptured MCAAs in a European industrialized country. Although patients with MCAAs presented with worse admission grades and greater rates of concomitant ICH, in-hospital mortality was lower and long-term disability was comparable to those in patients with non-MCAA.
引用
- Maldaner N, Steinsiepe VK, Goldberg J, et al. Patterns of care for ruptured aneurysms of the middle cerebral artery: analysis of a Swiss national database (Swiss SOS). J Neurosurg. 2019. PMID: 31731273. doi:10.3171/2019.9.JNS192055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。